Pregnancy and Birth

The comprehensive review found no evidence linking HPV vaccination to neurological conditions or adverse pregnancy outcomes across 20 years of data.

Following the presentation of real-world data at HRS 2026, Ridhima Kapoor, MD, details the importance of using continuous 14-day ECG patches to capture arrhythmia burden in pregnant populations.

The review of over 120 studies published since 2024 found no credible evidence linking HPV vaccination to serious adverse pregnancy outcomes or other long-term health risks.

Per CNN, Alito’s order is in effect until May 11, with responses to the case requested by Thursday, May 7.

During clinical validation done by the company, Unity Confirm demonstrated 100% concordance with known fetal outcomes and invasive diagnostic results in 16 samples.

Maternal dairy intake was consistently associated with lower concentrations of numerous human milk lipid species.

Nicole Sparks, MD, discusses anesthesia approaches, evolving c-section trends, and the growing emphasis on opioid-sparing pain management and postpartum recovery.

Data presented at HRS 2026 indicates that nearly 60% of arrhythmias in pregnant patients are first detected after the initial 48 hours of cardiac monitoring.

The expanded label to include use during pregnancy complicated by type 1 diabetes mellitus is based on data from the CIRCUIT trial.

"Results remained similar in subgroup analyses of early- and late-onset, and preterm and term preeclampsia," according to findings.

Effective January 1, 2027, the Current Procedural Terminology codes will replace the global maternity payment model to bill for antepartum, labor, delivery, and postpartum phases.

The incidence of SUI at 6 weeks post partum was 8.7% for the PEFLOW group compared to 13.9% for those receiving usual care (P = .03).

Conditions like chorioamnionitis change the pH of the surgical environment, which can prevent local anesthetics from working optimally, according to Beth Ann Clayton.

New research indicates significant disparities in immediate STI antibiotic administration in emergency departments based on pregnancy status.

Scott Sullivan, MD, describes a new strategy of training ER staff in hospitals without OB services to manage "drop-in" obstetric emergencies through simulation and remote support.

According to Amy Sarma, MD, moving beyond episodic office visits to multimodality care strategies is essential for reducing adverse cardiovascular outcomes in high-risk patients.

Scott Sullivan, MD, highlights that a third of Virginia is a maternity desert, creating even more severe gaps for patients requiring maternal-fetal medicine.

Routine ultrasound screening at 35 to 37 weeks demonstrates limited accuracy for large-for-gestational age according to new data published in AJOG.

"Given the upper limits of the CI, a relatively higher risk of more than 12% for autism is unlikely to be associated with acetaminophen exposure," the study authors noted.

MMRC data highlight that preventing pregnancy-related infection deaths requires multilevel interventions spanning patient education, provider training, and system readiness, with the AIM obstetric sepsis bundle representing a practical framework while broader outcomes evidence remains limited.

Investigators behind a national EHR study of perinatal GLP-1 RA prescribing acknowledge that the data cannot distinguish inadvertent early-pregnancy exposure from planned preconception discontinuation, and call for deeper, outcomes-focused research to build on the prescribing trends they identified.

The FDA has granted 510(k) clearance to Sibel Health’s ANNE Maternal, the first fully wireless platform for continuous, simultaneous maternal and fetal monitoring in labor, delivery, and the postpartum period.

While mortality declined by 9.8% in non-ban states, states with abortion bans saw much smaller declines and descriptive increases among non-Hispanic Black and Asian individuals.

New data from JAMA Cardiology indicates that 17.8% of women developed hypertension within 7 years of their first pregnancy, influenced by genetics, BMI, and HDP history.

In this discussion, Ramu Perni, MD, MBA, details the benefits of using a non-invasive prenatal red blood cell fetal antigen test for pregnancies affected by or at risk for HDFN.